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It is now possible to significantly reduce the risk of HIV
transmission from mother to child, provided the woman’s
HIV status is known. Most OECD countries now offer some
form of routine antenatal screening.1 The Ministry of Health
(MOH) in New Zealand circulated provisional guidelines for
routine HIV risk assessment in 1997. However, as presented
in the companion article, in this issue of the Journal, recent
evidence shows that antenatal women are not routinely
assessed for HIV risk or offered HIV testing, at least not in
the South Island, nor are they informed of the effective
treatment to prevent mother-to-child transmission.  As of 31
December 2000, twelve children in New Zealand were
known to be infected with HIV by perinatal transmission.2
International studies suggest that the probability an HIV-
positive woman will transmit the virus to her baby during
pregnancy, labour, delivery, or breastfeeding ranges from 
15-25% in an industrialised country, with no intervention.3,4
Since 1992, the number of women living with diagnosed
HIV infection in New Zealand has nearly tripled.5
In February 1994, the Pediatric AIDS Clinical Trials
Group (PACTG) Protocol 076 demonstrated that
zidovudine (or AZT), could reduce the risk for mother-to-
child HIV-1 transmission by nearly 70%.6 In early 1998, the
results of shorter regimens of zidovudine in three developing
countries showed a 50% reduction in the risk of mother-to-
infant HIV transmission at a cost of only US$50.7 A team of
researchers from Johns Hopkins University in Kampala
demonstrated that a single dose of nevirapene to a woman in
labour and to her baby within three days of birth, cut the
transmission rate by 47%, for only US$4.8 By June 1999, the
relative risk of vertical transmission was reduced to around 
1-2% when elective caesarean-section delivery was combined
with zidovudine in a randomised clinical trial conducted by
the European Collaborative Study.9 These findings have
prompted important changes to the standards of screening
practice for maternity carers in all OECD countries.1
A US Centers for Disease Control and Prevention (CDC)
literature review of women’s acceptance of HIV testing,
concluded that client-directed counselling, routine offer of
the HIV test, and understanding the medical and social
benefits of testing were factors found to most likely result in
acceptance.10 The uptake of HIV testing among antenatal
women shows different results where strategies have varied
from universal offer, to selective offer, to opt-out offer, to
testing only women who request it or opt-in.11-13 The results
of a randomised controlled trial in Edinburgh recently
concluded that the universal offer of HIV testing is
acceptable to pregnant women and when offered in a routine
manner, resulted in higher uptake, without increased anxiety
or dissatisfaction.11 Regardless of the strategy, it has been
repeatedly demonstrated that when women are aware of their
HIV status, they want to manage their pregnancies to reduce
the risk of infection to their babies.13
The first acceptability study among antenatal women
conducted in New Zealand was commissioned by the MOH
and conducted by Fursman in Wellington just prior to the
release of the circular letter in 1997. This study found that
knowledge of HIV in general and of HIV and pregnancy in
particular was high, but there was little awareness of the
reductions in vertical transmission associated with AZT.14
Once informed of the effective treatment, respondents felt
that having an HIV test would be ‘useful’ and that the
benefits outweighed any drawbacks. In contrast, women’s
acceptability of HIV testing was perceived as a significant
barrier by most maternity care providers, as shown in the
results of two provider surveys conducted in Otago in 1998
and in Canterbury-West Coast in 1999.15,16
In response to these study results, the availability of an
effective treatment, and the provisional MOH guidelines
which called for further research, the Women’s Acceptability
of Screening HIV (WASH) study was funded in September
1999. The purpose of WASH was to investigate the
acceptability of HIV testing among women of reproductive
age in Christchurch.  
Methods
65 women from different socio-demographic and ethnic backgrounds
were recruited and referred by staff from seven community service and
clinic sites in Christchurch using a recruitment check list prepared by the
WASH research team. In the clinic sites, consecutive attenders were
approached within the designated three-week recruitment period. The
study team was reliant on staff members in the different services to
remember to approach women.  This did not occur as efficiently in some
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Abstract 
Aims. To elicit acceptability of HIV screening during
pregnancy in women of reproductive age in Christchurch.
Methods. In-depth face-to-face interviews were conducted
with women of reproductive age recruited from seven
different service sites in Christchurch.
Results. Women wanted to know about treatment that
significantly reduces the risk of mother-to-child
transmission. They wanted to know about other antenatal
screening and were prepared to provide general consent,
rather than specific consent for HIV testing. All study
participants favoured routine offer of HIV testing during
pregnancy for all women and most would agree to be tested,
if the test was offered and recommended.
Conclusions. The results of this study indicate the need to
develop and test a user-friendly approach for offering routine
HIV testing during standard antenatal care in New Zealand.
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sites as in others.  The Maori, Pacific Island, Cambodian, and Ethiopian
women were approached by health workers from their own communities
in the same time period when they attended regular meetings and training
programmes. Women were eligible if they were nulliparous, antenatal,
one to two years postpartum, and/or considering pregnancy. Women with
no immediate or long-term plans for pregnancy were screened out.  
The specific service sites that were deliberately engaged in this study
represented the team’s best opportunity to recruit as wide a socio-
economic and ethnic variety of women of reproductive age in
Christchurch as possible.  Budget constraints precluded a larger sample.
While other ethnic groups are represented in the refugee community,
limited resources restricted recruitment. The research team made its
selection by prioritising one group from the African continent where the
HIV/AIDS epidemic has raged for two decades and one group from
Southeast Asia, where the epidemic is more recent but equally volatile.  
Fourteen of the 65 referrals were either unable to be scheduled or
withdrew.  51 women were interviewed (Table 1). Two interviews were lost
due to failure of taping equipment, leaving a total of 49 participants.  Each
participant completed an in-depth semi-structured interview in
September-October 1999 to assess general HIV knowledge, knowledge
related to pregnancy and breast feeding, perceptions of personal risk, and
preferences for HIV screening techniques and provider practices.  The
interview schedule included dichotomous, Likert scale, forced choice, and
limited choice style questions conducive to quantitative analysis. The
versatility of the interview method allows qualitative and quantitative
analysis methods to be combined in a complementary fashion, especially
where the assessment of complex issues such as HIV/AIDS is undertaken.
The results from the quantitative questions were further validated and
enriched with the qualitative analysis of responses from the more open-
ended questions.  All interview data were coded and entered into an
ACCESS database that accommodated both quantitative and qualitative
data entry fields.  The interview method was chosen because it offers the
flexibility to explore reasons for personal preferences and to respond to
any concerns or questions in a private and personal data-gathering
situation about a subject that is still considered sensitive and potentially
stigmatising. 
The 51 interviews were completed in less than five weeks by three female
interviewers, including two of the co-investigators and one Senior
Research Officer whose skills helped establish rapport and an
environment of trust and disclosure. The decision to use three
interviewers was based on time and resource constraints as well as respect
for cultural appropriateness, ie the Maori Co-Investigator interviewed all
Maori participants. All interviews were conducted in the participant’s
home, at Te Waipounamu Centre, or at 45 Cambridge Terrace
(Department of Public Health & General Practice) and lasted 100 minutes
on average.  All interviews were tape recorded and transcribed.   
The original WASH research design proposed Focus Group
Discussions (FGDs) with all participants following the interviews in order
to further investigate women’s preferences for the delivery of information
about HIV. Most women initially gave their consent to participate in both
the interview and the FGD. However, many were ambivalent about
joining a focus group following the interview, expressing that they had
little more to add.  Scheduling for the focus groups ran into the school
holidays, which added to the unanticipated difficulty. The results of the
few focus group discussions that did occur will be reported in another
publication.
Results
Recruitment data are shown in Table 1. Figures 1 and 2 show
that the women who participated in WASH were very much
like all women from the seven service sites who were offered
the opportunity to participate, in terms of employment
status, studying, having had an HIV test and age range.  The
interviewed women were slightly more likely to have
children and a long-term partner. 
Of the 49 WASH participants; 19 (59%) were New Zealand
European, 11 (22%) were Maori, 9 (18%) were Pacific
Islanders, 5 (10%) were Cambodian, and 5 (10%) were
Ethiopian.  Maori, Pacific Island, Cambodian and Ethiopian
women were over-sampled in response to the funding
agency’s request and in order to access the unique cultural
perspectives of these groups of women. Nationally, the
respective proportions of Maori and Pacific Island peoples to
the total population are 14 and 5%. In the territorial
authority of Christchurch these proportions are 7 and 2%
respectively, based on 1996 census data. Fifteen (33%) of
participants voluntarily disclosed they were pregnant during
the interview.
Participants were asked if they had heard about HIV or
AIDS. Over half said they had and most had received their
information from a variety of ‘other’ sources such as
magazines, school sexual health programmes, workshops,
office, friends and the movies, and not from the main media
such as television or newspapers. Responses from the ten
refugee women were incomplete for this question and were
not included in this analysis. 
WASH participants were asked 25 knowledge questions
regarding the transmission and prevention of HIV/AIDS.
These questions included nine ‘true/false’ statements,
fourteen ‘high risk/low risk/no risk’ activities, and two
‘yes/no’ questions regarding methods of transmission and
prevention.  Knowledge scores were calculated based on the
number of correct responses. Figure 3 presents the
distribution of correct knowledge scores.  Most scores were
in the 80th and 90th percentiles, about the same level of
HIV/AIDS knowledge demonstrated in other parts of the
world among the general public.17 30 participants, or 61%,
answered more than half of the general knowledge questions
correctly.  There were no measurable ethnic differences in
general knowledge. Study participants were also asked six
questions about the HIV test.  Knowledge about the HIV
test was not as high as general HIV knowledge, however,
Table 1. WASH recruitment sites, women approached, referred,
and interviewed.
Service Site Approached Referred Interviewed
1. Christchurch Women’s Hosp. 11 9 7 (13%)
2. ‘198’ Youth Health Centre 8 6 3 (6%)
3. Ngai Tahu Development Corp. 17 9 9 (18%)
4. Methadone Programme 3 2 2 (4%)
5. Family Planning Assoc. 72 17 11 (21%)
6. Crown Public Health, Ltd. 12 12 9 (18%)
7. Refugee & Migrant Centre 10 10 10 (20%)
Totals 133 65 51*
*Two interviews lost due to faulty audio equipment. Table shows % of total
number of women interviewed to illustrate variety of participants.
Figure 1. Women approached compared to women interviewed.
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Figure 2. Age groupings for women approached compared to
women interviewed.
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Maori women were slightly better informed about the HIV
test than the other women.
The relatively high general knowledge about HIV
transmission also contrasted with lower levels of knowledge
regarding effective treatment during pregnancy and risk
attributed to breast feeding. Almost all women, 47 (98%)
knew that ‘a mother who is HIV positive can pass the virus
on to her baby’, but only 20 women ( 41%) knew that not all
babies get the virus. Only 33% (16 women) were aware that
HIV can be transmitted through breast milk.   
Women’s perceptions of their own risk of being exposed to
HIV in the past five years and currently or ‘tomorrow’ were
assessed on a five point scale where 1 was ‘no chance’ and 5
was a ‘very high chance’.  Three women rated their risk of
exposure to HIV in the past as ‘very high’.  However, none of
the women rated their current risk as ‘very high’ and
approximately 75%, (38 women) perceived that they had ‘no
chance’ of currently being exposed to HIV.
WASH participants were asked a number of attitudinal
questions about HIV screening as part of antenatal care.
Most (86%) said they would have the test if it was offered and
more than half (68%) thought that knowing one’s HIV status
would help the baby. 82% said they would have the test if
they knew it was part of the antenatal ‘routine’ and that all
other pregnant women were having it too. Almost half,
(42%) said they thought they would have the test even if it
wasn’t part of the routine, and even if they thought that they
were the only one being offered the test.
The interviewers also explained that the doctor could be
required to ask a woman for specific permission for the test
during antenatal care, or the woman’s consent could be
provided when general permission for all antenatal screening
was given.  34 women (69%) said they preferred to give
general permission and only eleven (22%) said they wanted
specific consent for the HIV test.  One woman was ‘unsure’
and data from three women were missing.  
Midway through each interview and after responding to the
knowledge and attitudinal questions discussed above, all
participants were informed about the effective treatment for
minimising mother to child transmission of HIV.  Each
participant was then shown a card listing seven different
screening options (Table 2). Figure 4 shows that 96% of
participants expressed a preference for routine screening during
pregnancy, whether Option A, ‘routine compulsory’ selected by
16 (33%) participants, or Option B, ‘routine offer and
recommended’ selected by 31 (63%) participants. Most
Ethiopian and Cambodian women preferred the option of
compulsory screening, whereas most Maori, Pacific Islands, and
European participants preferred routine and recommended
offer of HIV testing, with women being able to opt out. Only
one participant chose option C (the same as the current MOH
provisional guideline) and another chose Option F, ‘No set
policy or practice on testing pregnant women for HIV.’ 
Screening preferences were then analysed in relation to self-
perception of risk and perceived drawbacks in order to detect
any patterns or influence. Most women who chose Option B
felt they were at low risk and there were no drawbacks to
having an HIV test. 
Discussion
The sample in the study was not intended to be
representative of women of reproductive age in New
Zealand.  However, because the results of the WASH study
were almost identical to those in the 1996 Wellington study
and very similar to the results of the randomised control trial
conducted in Edinburgh, they may reflect the views of many
New Zealand women.11 Women interviewed were similar to
all women approached for most socio-demographic variables.
However, those interviewed were more likely to have
children and a long-term partner.  It is important to note that
Maori and Pacific Island women are not known to be at
increased risk for HIV infection. They are known, however,
to seek and use health care services differently from
Europeans and their exposure to other sexually transmitted
infections (STIs) may be higher due to social and economic
factors that impinge upon their health status in general.18,19
The most difficult interviews and transcripts were those
involving Cambodian and Ethiopian participants.
Professional interpreters were recruited through the Refugee
and Migrant Centre and oriented to the interview schedule
by the Principal Investigator and lead-interviewer. The
migrant women preferred to be interviewed at home. In
almost all cases young children were present which often
resulted in interruptions and poor taping quality. In some
cases the interview could not be completed which accounts
for some missing data. 
By the conclusion of the interviews it was clear that almost
all 49 women were in favour of routine HIV screening during
antenatal care. Moreover, 86% said they would be willing to
have an HIV test if it were offered, even before they learned
about the effective treatment for preventing transmission
from mother-to-child.  The women were also much more apt
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Figure 3. Distribution of HIV/AIDS knowledge scores for 25
questions.
Table 2. Seven different screening options.
A. Routine compulsory testing for all women.
B. Offered an HIV test and recommended to have it, but a woman can turn the
offer down.
C. All women assessed for their risk of exposure to HIV and those at risk are
offered an HIV test.
D. All women in high HIV risk areas are offered an HIV test. Women in other
areas are offered the test if they are assessed as being at high risk of exposure
to the virus.
E. HIV testing is available but women have to ask for it.
F. No set policy or practice on testing pregnant women for HIV.
G.  Other approach?
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Figure 4. Women’s preferences for HIV testing option based on
interviews.
New Zealand Medical Journal512 23 November 2001
to identify benefits of routine HIV testing than drawbacks;
for themselves, for all women and for the babies. These
results contrast with results from the two providers’ studies
conducted in Dunedin and Canterbury and the upper South
Island that showed maternity care providers tend to think
that HIV screening is not acceptable for most antenatal
clients.15,16 Contrary to the providers’ perceptions, most
women favoured ‘general consent’ for all antenatal screening,
rather than ‘specific consent’ for HIV screening.    
The WASH study results clearly document that women
want to know about treatment aimed at reducing risk of
mother-to-child infection. They wanted to be offered HIV
screening as part of routine standard antenatal care. They
wanted to be informed about all antenatal screening and they
wanted to provide general consent for all antenatal screening.
WASH results further indicate that all women, especially
antenatal women, should be informed by their primary or
maternity care providers about HIV, the treatment available
for preventing mother to child infection, and the risks of
breast feeding.  Results from both the provider and women’s
studies in Canterbury suggest that the national guidelines for
all antenatal screening deserve to be reviewed.
To reconcile the differences between the providers’
preferences towards HIV screening during antenatal care
and the preferences of women, the research team has
developed several antenatal screening protocols and propose
to test their acceptability and uptake in a multi-centre study.
The primary intent will be to identify key factors that predict
uptake (eg uptake of the protocol among providers and
uptake of testing among clients) and to explore the
importance of informed consent for all antenatal screening.  
There is a unique blend of ethnic cultures in New Zealand,
which makes it important to ensure that the most acceptable
methods of screening are developed.  The research team
expects to work with professional bodies such as the Colleges
of General Practitioners, Obstetricians and Gynaecologists,
and Midwives to trial the antenatal screening protocols.
Acceptable methods of identifying HIV infected women in
pregnancy are urgently required to bring New Zealand into
line with other Western countries and to minimise perinatal
transmission of a preventable infectious disease.
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Dr Stuart Brown, Meadowbank, Auckland was lightening his load of files and came across a
cartoon by Minhinnick from just prior to World War II. It portrayed “Mick” Savage, Prime
Minister of the day, at the time of the first Labour Government, and his approach to the New
Zealand branch of the BMA. He wondered if there was a parallel in the attitude of recent
governments toward the medical profession.
